Research Study Comparing a New Medicine " Fast-acting Insulin Aspart " to Another Already Available Medicine " NovoRapid " / " NovoLog " in People With Type 2 Diabetes
Conditions: Diabetes; Diabetes Mellitus, Type 2 Interventions: Drug: Faster-acting insulin aspart; Drug: Insulin aspart; Drug: Insulin degludec; Drug: Metformin Sponsor: Novo Nordisk A/S Not yet recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Condition: Type 1 Diabetes Mellitus Interventions: Drug: Humalog; Drug: Novolog; Drug: Apidra; Device: Bionic Pancreas Sponsors: Massachusetts General Hospital; Boston University Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2017 Category: Research Source Type: clinical trials